Concepedia

James Kalabus

JK

Statistics

Publications

14

Citations

793

H-Index

13

Active since

2008

Affiliations

University at Buffalo, State University of New York(Current)

Amgen (United States)

Boehringer Ingelheim (Germany)

Universität Ulm

Université Fédérale de Toulouse Midi-Pyrénées

James Kalabus is an author at University at Buffalo, State University of New York specializing in medicine, natural sciences, and hematology.

ORCID

Top concepts

Publications per year

2008–2023

14

Publications

14

Anti–B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma

Max S. Topp, Johannes Duell, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2020 · 292 citations

miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes

Andrew E. Bruno, Li Li, James Kalabus et al. · BMC Genomics · 2012 · 169 citations · Full text

Evaluation of AMG 420, an anti-BCMA bispecific T-cell engager (BiTE) immunotherapy, in R/R multiple myeloma (MM) patients: Updated results of a first-in-human (FIH) phase I dose escalation study.

Max S. Topp, Johannes Duell, Gerhard Zugmaier et al. · Journal of Clinical Oncology · 2019 · 55 citations

, , +17

Preclinical Characterization and Phase I Trial Results of INBRX-109, A Third-Generation, Recombinant, Humanized, Death Receptor 5 Agonist Antibody, in Chondrosarcoma

Vivek Subbiah, Sant P. Chawla, Anthony P. Conley et al. · Clinical Cancer Research · 2023 · 40 citations · Full text

Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors

Vanessa González-Covarrubias, Jianping Zhang, James Kalabus et al. · Drug Metabolism and Disposition · 2008 · 39 citations · Full text

1–5 of 14